Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

Dieter, SM; Heining, C; Agaimy, A; Huebschmann, D; Bonekamp, D; Hutter, B; Ehrenberg, KR; Frohlich, M; Schlesner, M; Scholl, C; Schlemmer, HP; Wolf, S; Mavratzas, A; Jung, CS; Groschel, S; von Kalle, C; Eils, R; Brors, B; Penzel, R; Kriegsmann, M; Re

Frohling, S (reprint author), NCT Heidelberg, Dept Translat Oncol, Neuenheimer Feld 460, D-69120 Heidelberg, Germany.

ANNALS OF ONCOLOGY, 2017; 28 (1): 142

Abstract

Background: Sinonasal carcinomas (SNCs) comprise various rare tumor types that are characterized by marked histologic diversity and largely unknown mo......

Full Text Link